Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex
about
Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy.Safety of an intravenous formulation of lamotrigineSex differences in the neurobiology of epilepsy: a preclinical perspective.Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic PatientsSteady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodologyBioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsyAssociation of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures.Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.Interference-free Determination of Carbamazepine in Human Serum Using High Performance Liquid Chromatography: A Comprehensive Research with Three-way Calibration MethodsPharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to go.Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.Intravenous Carbamazepine for Adults With Seizures.Intravenous carbamazepine: a new formulation of a familiar drug.Effects of carbamazepine combined with vitamin B12 on levels of plasma homocysteine, hs-CRP and TNF-α in patients with epilepsy.
P2860
Q30830721-7FF9DD04-FC6A-4CFB-8156-01672BD982BAQ33622067-CD5173AE-0ECF-4B54-AC83-ED0F5125F6F6Q34616106-EBD67E0E-79E2-401C-91C7-7154325DDAFFQ35837256-2EAF3FF4-ECBC-44D1-952F-29AFDA4907EAQ36021177-65D9D9AD-E2DD-4030-AE19-090AE5C28104Q36364659-D90E7525-7C15-4A0A-92DD-BA023323A1DFQ36603317-848C1C83-4BC6-4D9D-AB71-47F639712872Q36989348-0F8A0E52-85D1-485A-ADA0-B190B8F33A8BQ38179459-5EF44EDC-9705-4FC5-B8E8-FD7740B70E94Q38646868-D4760DB9-37C9-44C0-A5AC-0D16A0F0AA5CQ38790732-A50E0F19-4273-43F6-97AC-6168242B32E7Q38902279-2C018E78-54D5-46F3-A700-B8D1C78918ABQ41014928-D358338D-BA58-4F34-8F1B-0389B2CEC071Q42696352-93447B42-7654-43A9-A5DB-13BA7858C4F2Q47699933-05551EAA-8B0F-414F-B639-879BD5BCCA94Q52643630-04FBF924-DCAB-4963-B591-3FC6EDC7DB07
P2860
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Steady-state carbamazepine pha ...... ients: effects of race and sex
@ast
Steady-state carbamazepine pha ...... ients: effects of race and sex
@en
type
label
Steady-state carbamazepine pha ...... ients: effects of race and sex
@ast
Steady-state carbamazepine pha ...... ients: effects of race and sex
@en
prefLabel
Steady-state carbamazepine pha ...... ients: effects of race and sex
@ast
Steady-state carbamazepine pha ...... ients: effects of race and sex
@en
P2093
P2860
P356
P1476
Steady-state carbamazepine pha ...... ients: effects of race and sex
@en
P2093
A K Birnbaum
I E Leppik
J M Conway
J O Rarick
P B Pennell
R C Brundage
P2860
P304
P356
10.1038/CLPT.2011.251
P407
P577
2012-01-25T00:00:00Z